Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
MDV New	US$17.89	2.6%	21.7%	US$213.2m	US$18.67	1.2	149.5%	6.7%	Real Estate
SFC	CA$8.58	1.4%	6.6%	CA$1.2b	CA$12.19	31.9	87.8%	5.0%	Insurance
KINS	US$20.12	4.4%	29.3%	US$291.4m	US$21.50	9.4	20.8%	1.0%	Insurance
FNLC	US$35.04	0.3%	28.3%	US$395.1m	n/a	1.4	n/a	4.2%	Banks
ILPT	US$8.95	-4.4%	97.6%	US$596.7m	US$9.65	1.2	14.1%	2.2%	Real Estate
APPN	US$24.40	8.5%	-21.8%	US$1.8b	US$26.20	2024.0	108.9%	n/a	Software
UNB	US$25.57	5.8%	-7.5%	US$118.0m	n/a	1.5	n/a	5.6%	Banks
PEBO New	US$38.71	2.1%	21.9%	US$1.4b	US$38.17	1.1	14.2%	4.3%	Banks
AVIA	Rp320.00	4.6%	-26.3%	Rp18.9t	Rp510.80	10.5	5.8%	6.9%	Materials
PGC New	AU$0.15	15.4%	-62.0%	AU$248.3m	AU$0.25	0.1	96.0%	n/a	Healthcare
QUEST	€7.15	2.0%	-3.6%	€765.1m	€10.00	15.3	13.3%	5.6%	Tech
BTPS New	Rp1,000.00	3.1%	-27.8%	Rp7.7t	Rp1,463.50	0.7	10.8%	4.0%	Banks
EW	₱12.18	0.2%	9.1%	₱27.4b	₱13.70	0.3	n/a	5.6%	Banks
DDR	AU$11.59	-5.1%	38.1%	AU$2.1b	AU$11.21	24.5	7.4%	3.8%	Tech
OCE	R69.31	3.4%	31.9%	R8.2b	R90.00	11.7	8.3%	4.1%	Food, Beverage & Tobacco
354	HK$3.08	3.7%	-36.4%	HK$7.7b	HK$4.02	20.8	30.2%	1.5%	Software
KLBF New	Rp750.00	-3.8%	-50.0%	Rp33.9t	Rp1,307.50	9.4	7.6%	4.8%	Pharmaceuticals & Biotech
FCL	AU$2.04	-7.3%	-22.4%	AU$703.5m	AU$3.32	453.7	39.2%	n/a	Software
OU8	S$1.48	0%	-14.0%	S$1.2b	S$1.88	10.8	-0.3%	2.7%	Real Estate Management and Development
BCI	AU$0.41	6.4%	22.1%	AU$1.2b	AU$0.63	319.0	47.6%	0%	Materials
NMAN	SEK 135.40	5.5%	-24.7%	SEK 4.8b	SEK 159.00	18.2	18.2%	3.0%	Capital Goods
CEVI	SEK 143.40	5.9%	-20.8%	SEK 3.5b	SEK 177.75	25.5	16.7%	1.9%	Healthcare
CVSG	UK£12.42	5.5%	2.1%	UK£872.7m	UK£16.40	52.8	21.0%	0.7%	Healthcare
BILI A	SEK 143.80	-0.1%	10.4%	SEK 13.4b	SEK 162.00	16.4	15.1%	4.2%	Retail

Undervalued Small Caps With Insider Buying